Adrenergic blocking agents. A double-blind trial in the treatment of the eye signs of thyroid disorders.
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001949:Bretylium Compounds / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004487:Edema; D005094:Exophthalmos / Q000188:drug therapy; D005128:Eye Diseases / Q000188:drug therapy*; D005132:Eye Manifestations; D005260:Female; D006145:Guanethidine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions; D009915:Orbit; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D001949:Bretylium Compounds; D009883:Ophthalmic Solutions; D013565:Sympatholytics; D011433:Propranolol; D006145:Guanethidine